Cidara Therapeutics (CDTX) P/E (2015 - 2026)
Cidara Therapeutics (CDTX) P/E from Apr 15, 2015 to Jan 7, 2026. The TTM Cidara Therapeutics (CDTX) P/E is -78.03. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Cidara Therapeutics (CDTX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -78.03 | +0.22% |
| 2025 | -77.86 | +1284.09% |
| 2024 | -5.63 | -28.62% |
| 2023 | -7.88 | -319.28% |
| 2022 | 3.59 | -170.05% |
| 2021 | -5.13 | +23.63% |
| 2020 | -4.15 | -68.25% |
| 2019 | -13.07 | +63.40% |
| 2018 | -8.00 | -65.44% |
| 2017 | -23.15 | -34.62% |
| 2016 | -35.40 | -39.39% |
| 2015 | -58.41 | N/A |
Comparison Cidara Therapeutics (CDTX) P/E with competitors
Cidara Therapeutics (CDTX) P/E is -78.03.